Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Wenzel

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Dermatology and Therapy|February 23, 2021
Grzybowski's Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease-An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case ReportRegina Havenith, Luka de Vos, Anne Fröhlich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2012
Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institutionTorsten Hinz, Hojjat Ahmadzadehfar, Anja Wierzbicki, et al.
Frontiers in Immunology|April 4, 2024
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case reportTanja Fetter, Simon Fietz, Maya Bertlich, et al.
Lupus Science & Medicine|October 24, 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib studyTorsten Witte, Ruth Fernandez-Ruiz, Nadezda Abramova, et al.
The Journal of Dermatology|March 7, 2024
International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus ErythematosusMinoru Hasegawa, François Chasset, Benjamin F Chong, et al.
International Journal of Dermatology|February 14, 2017
The role of histological presentation in erythrodermaMatteo Megna, Akmal A Sidikov, Denis V Zaslavsky, et al.
Journal of the American Academy of Dermatology|February 19, 2008
CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host diseaseJoerg Wenzel, Svenja Lucas, Sabine Zahn, et al.
Experimental Dermatology|February 25, 2016
Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patientsChristine Braegelmann, Michael Hölzel, Valerie Ludbrook, et al.
Dermatology (Basel, Switzerland)|April 6, 2011
High-resolution ultrasound combined with power Doppler sonography can reduce the number of sentinel lymph node biopsies in cutaneous melanomaTorsten Hinz, Dagmar Wilsmann-Theis, Andrea Buchner, et al.
Frontiers in Immunology|June 8, 2026
Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understandingVictoria P Werth, Lars Rönnblom, Joerg Wenzel, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Dermatology and Therapy|February 23, 2021
Grzybowski's Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease-An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case ReportRegina Havenith, Luka de Vos, Anne Fröhlich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2012
Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institutionTorsten Hinz, Hojjat Ahmadzadehfar, Anja Wierzbicki, et al.
Frontiers in Immunology|April 4, 2024
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case reportTanja Fetter, Simon Fietz, Maya Bertlich, et al.
Lupus Science & Medicine|October 24, 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib studyTorsten Witte, Ruth Fernandez-Ruiz, Nadezda Abramova, et al.
The Journal of Dermatology|March 7, 2024
International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus ErythematosusMinoru Hasegawa, François Chasset, Benjamin F Chong, et al.
International Journal of Dermatology|February 14, 2017
The role of histological presentation in erythrodermaMatteo Megna, Akmal A Sidikov, Denis V Zaslavsky, et al.
Journal of the American Academy of Dermatology|February 19, 2008
CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host diseaseJoerg Wenzel, Svenja Lucas, Sabine Zahn, et al.
Experimental Dermatology|February 25, 2016
Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patientsChristine Braegelmann, Michael Hölzel, Valerie Ludbrook, et al.
Dermatology (Basel, Switzerland)|April 6, 2011
High-resolution ultrasound combined with power Doppler sonography can reduce the number of sentinel lymph node biopsies in cutaneous melanomaTorsten Hinz, Dagmar Wilsmann-Theis, Andrea Buchner, et al.
Frontiers in Immunology|June 8, 2026
Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understandingVictoria P Werth, Lars Rönnblom, Joerg Wenzel, et al.
Pageof 9